Morsi’s Iran Visit: Three Things to Know
Videos

Morsi’s Iran Visit: Three Things to Know

August 30, 2012 3:04 pm (EST)

Morsi’s Iran Visit: Three Things to Know
Explainer Video

Newly elected Egyptian President Mohamed Morsi’s attendance at the Non-Aligned Movement summit in Tehran marks the first visit by an Egyptian leader to Iran in decades, after diplomatic ties between the two countries were severed in 1979. CFR’s Hasib J. Sabbagh Senior Fellow for Middle Eastern Studies, Steven A. Cook, highlights three things to know about the visit:

More From Our Experts

Domestic posturing: Morsi’s visit is first and foremost about domestic politics, Cook says. Former president Hosni Mubarak’s foreign policy was profoundly unpopular with the vast majority of Egyptians, he explains, and President Morsi and the Muslim Brotherhood are eager to demonstrate that this is a "new era" in Egyptian foreign policy.

Regional ambitions: The Muslim Brotherhood and President Morsi are also seeking to "establish a foreign policy that is independent of the United States," Cook says, which they hope will help Egypt "regain its lost regional luster and influence."

Washington takeaways: These developments "are not necessarily bad things for the United States," Cook emphasizes. If Morsi’s approach is successful in reestablishing Egypt’s regional leadership in the Middle East, it will become "a more appropriate interlocutor for the United States," he says.

More From Our Experts
Close

Top Stories on CFR

Israeli-Palestinian Conflict

An impending Israeli ground invasion of Rafah could threaten more than a million civilians seeking refuge in the city and further restrict humanitarian aid into the Gaza Strip.

Maldives

Once a close Indian partner, the Maldives is now aligning more with China. Is the island nation becoming a flash point in the China-India relationship? 

Public Health Threats and Pandemics

A global surge in avian flu outbreaks in birds and some mammals is worrying poultry farmers, scientists, and health experts. The trend is provoking questions about the future of the disease and global public health.